Objective Candiduria is a common finding in the growing population of very old patients that has not been previously studied. The objective was to study candiduria in the population aged 85 and over, including an estimation of the incidence, factor of acquisition, and evaluation of treatment and mortality. Methods retrospective monocentric study. Materials medical charts of patients aged of 85 and over who have candiduria diagnosed at Nimes University Hospital. Results The prevalence of candiduria in the hospitalized very old patients was 8.9%. More than half of strains isolated were C. albicans (59%). Mean age was 89.7 years old with 53 women and 20 men. Urinary catheter (55%) and prior antibiotic use (67%) were commonly found. Fifteen patients with candiduria were treated, consistently with fluconazole. Patients treated had higher Mini Mental Test score than the others. A high C-reactive protein level, Mac Cabe score or Charlson's score >7 were associated with 6 months mortality. Conclusion Episodes of candiduria in oldest old were associated with frailty and vulnerability of the patient. The medical decision for antifungal treatment is usually difficult to make but it did not seem to influence mortality.
Introduction
Candiduria is common in hospitalized patients with an estimation of about 75,000 cases per year in the United States (1) . Risk factors for acquisition, the clinical characteristics and significance of candiduria have been published primarily in relation to intensive care unit and immunecompromised patients (2) (3) (4) . Diabetes mellitus, prolonged use of antibacterial agents, indwelling urinary catheter, genitourinary tuberculosis, chronic renal failure, malignancy, neutropenia, immunosuppressive therapy, urinary tract instrumentation, surgery, renal graft, female sex and extremes of age are known risk factors of acquisition of candiduria (5) . The "oldest old", 85 years of age and older, patients represent an important and still growing population in developed countries. In France, on January 1, 2009, the number of 85 years of age and older people totaled 1.5 million. By 2050, this age group will be multiplied by four. From 1960 to 1990, the number of Americans 85 years of age or older increased by 232 percent reaching 3.5 million (6) . Most of the practitioners in hospitals or in the community will be concerned regarding the care of these patients. The comorbidities, medications, and sometimes disability, often make care of the oldest old difficult (6) . The older age is a classical risk factor of candiduria. To our knowledge, it has never been described in the oldest. In this retrospective study, the prevalence of candiduria, and the clinical characteristics, including classical risks factor for acquisition of candiduria, were evaluated in the specific popu-lation of the oldest old hospitalized patients. Risk factors of death during hospitalization or at 6 months were then studied.
Methods
A retrospective analysis of medical charts was done in our hospital. It is an university tertiary care French hospital with 1844 beds of short and intermediate term care (emergency unit, intensive care unit, medical and surgical units, and readaptation) and 500 beds of long term care. It was an observational study without intervention, so a local ethic committee statement was not needed. All hospitalized patients, of 85 years old and more, whose urine cultures, analyzed in our microbiology laboratory, led to identification of Candida spp. >10 5 ufc/mL were included between January 1, 2008 and December 31, 2008. Only the first occurrence of candiduria per patient was analyzed. A leukocyturia >10 4 / mL was required for the definition of candiduria in patients free of urinary catheter. All specimens collected by midstream urinary technique or via indwelling urinary catheters were eligible for inclusion. Urine cultures were not routinely done on admission to the hospital. According to medical presentation, urine cultures were prescribed by the practioner in charge of the patient.
Demographic and medical data, including, age, gender, weight, classic risk factors of candiduria acquisition (diabetes mellitus, presence of an indwelling urinary catheter, immunosuppressive therapy, urinary tract lesion, antibacterial agent used during the week before the onset of candiduria), fever, glomerular filtration estimated by the MDRD (8), leukocyturia, blood culture results, C-Reactive Protein level, white blood cells count and also urinary tract morphologic exam were retrospectively collected from the patient's medical record for the first occurrence of candiduria.
Body mass index, lymphocyte count and albuminemia to assess the nutritional status, Mini Mental Status Examination of Folstein (9) to evaluate the cognitive status, place of living before hospitalization (institution or home), the number drugs taken and type of disease and the Charlson's score for comorbidities (10) were collected. Antifungal therapy was also studied (drug and way of administration).
Vital status at the end of hospitalization and within 6 months after study inclusion was assessed by systematic calling of the general practitioner.
Statistical Analysis
Descriptive statistics were used to characterize the population treated with antifungal treatment. Discrete variables were expressed as counts with percentages and continuous data were expressed as mean ± SD. Categorical data were compared using χ 2 test or Fisher's exact test, as appropriate, and continuous variables were compared using the Student t test. The Mann-Whitney U test and the Wilcoxon rank test were used to compare continuous variables non-normal distributed. A stepwise logistical regression was used to examine the independent contribution of factors that have been associated with antifungal treatment in the univariate analysis. Variables that were significantly associated (p<0.05) with antifungal treatment in the univariate analysis were included in the multivariate model, taking into account the colinearity between these variables. Model checking was performed using Hosmer and Lemeshow goodness-of-fit testing. A p value !0.05 was considered significant. For identification of association with mortality, subjects with candiduria who died were compared to those who survived during hospitalization. All statistical analyses were performed with SAS software, version 8.02 (SAS Institute, Inc., Cary, NC).
Results
During the study period, 2773 urinary analyses were performed for 821 patients older than 85 years. One hundred episodes of candiduria occurred in 73 patients. The prevalence of candiduria was estimated at 8.9% of the oldest old population in our hospital. Candida albicans was isolated 59 times followed by C. glabrata 24 times, less common species were: C. Kefyr 3 times, C. lusitaniae 2, C. krusei and C. tropicalis one time. Candida sp., without species identification, was noted for 10 episodes. Only the first occurrence of candiduria per patient was analyzed in our study.
The mean age was 89.7 ± 3.9 years old with 53 females and 20 males. Fifty-two patients lived at home (73%). Charlson's score was higher than 2 for 43 patients (59%). Twenty (27%) patients had diabetes mellitus. Moderate renal insufficiency (11) was common in this population as suggested by the mean glomerular filtration value: 59 ± 25 mL/ min/1.73 m 2 . Eight patients (11%) had less than 20 mL/min/ 1.73 m 2 . MMS estimation at basal level was available for 28 patients (38%): 12 (42%) had score <15 corresponding to severe dementia and 8 (29%) a MMS of between 15 and 22. The mean body mass index was calculated for 33 patients (45%) and was 26 ± 5. The mean albumin value was estimated at 25 ± 5 g/L (estimated from 56 patients) and was under 30 g/L in 96% of patients. The mean number of drugs received per patient was high (9.6) and 56 patients (76%) took more than 7 different drugs.
Classical risk factors for candiduria were commonly encountered as vesical catheters (55%), and previous administration of antibacterial drugs (67%). Leukocyturia (>100.000 leukocytes by milliliter) was present 51 times (70%). In 15 patients (20%), candiduria episode was associated with bacteriuria, generally E. coli (53%) and Enteroccocus spp (13%). Fever (>38.5°C) was noted in 44 patients (60%). White blood count mean value was 11.350 (±6530) leukocytes/mm 3 and C-reactive protein mean level 90 (±76.9) mg/L for 71 patients. Morphologic examination of urinary tract was performed for 27 patients (37%) and only two presented a urinary tract dilatation. Blood cultures were performed in all febrile patients without candidemia identi- 
fied.
One patient died before completion of urine analysis results and was not included in the analysis of antifungal therapy. Antifungal treatment was administered only for 15 patients (21%) having C albicans candiduria. Fluconazole was always used. It was administered orally for 80% of patients. Table 1 give the analysis of factors associated with antifungal administration. Fever was not significantly associated with the prescription of fluconazole (p=0.09, using χ 2 test). A higher cognitive status (MMS!22) was, on univariate analysis by logistic regression, associated with antifungal therapy (Odds Ratio (OR) 1.21, 95% confidence interval (CI) [1.003-1.45]). Charlson's score for comorbidities was not associated with the prescription of antifungal therapy (p=0.13). The mortality at 6 months was not significantly associated with antifungal therapy (OR 1.06, 95% CI [0.33-
3.39]).
Twenty-one patients died during their hospitalization, and at six months the mortality rate was 29/73 (39.7%). Table 2 presents factors associated with death during hospitalization and at 6 months from univariate analysis. Charlson's score of 7 and more was significantly associated with the risk of death whether during hospitalization or at 6 months. The CRP level was significantly higher in the group of patients who died (p<0.005). The low level of albumin and number of patients having less than 30 g/L of albumin were associated with mortality during hospitalization. A lower weight was associated with 6 months mortality. Candiduric patients who died at six months were also older than those who survived. All deaths occurred in patients who were admitted in medicine department when candiduria was diagnosed whereas the place of daily living was not statistically associ- 
Discussion
There are very few studies about urinary tract infections among the oldest old (13, 14) and none about candiduria. Candiduria seems to be a common situation in the oldest old patients with a prevalence of 9%. Because a urinary analysis was not systematically done to every old patients admitted to our hospital, this prevalence is probably an underestimation of the true prevalence of candiduria in the elderly. Direct comparison of the candiduria rates between institutions is difficult due to the lack of standardized denominator data and case mix differences. However our finding was quite similar to previous studies done in younger populations: 10% found in a large European one day laboratory point prevalence study (15), 4.7% in a single center experience (16) . The prevalence of candiduria in oldest old was lower than in intensive care unit where prevalence varies from 19 to 42% (2).
We found for repartition of species of candida in the oldest old population the same trends as in the adult population (17) . The main species found were C. albicans (59%) followed by C. glabrata. Other species were anecdotal in proportion (1-3% of episodes) but could be associated to resistance to fluconazole. C. parapsilosis is rarely present in the urine of adults as opposed to urine of neonates who generally had systemic infection associated with candiduria (18) .
Although most of the patients lived at home, the population described was frail. The Charlson's score was high and they received multiple drugs. Diabetes mellitus, hypoalbuminemia, cognitive or renal impairment were also common. Classical risk factors of candiduria (5) as urinary catheter or prior antibiotic use were commonly found (more than 50% of patients). Some patients had immunosuppressive therapy (corticosteroids) or parenteral nutrition. The cause and result relationship of this association of vulnerability and candiduria could not be determined. Indeed, frailty or vulnerability and candiduria have some common risk factors such as diabetes mellitus or chronic use of an indwelling urinary catheter. No episode of candidemia was identified despite the frailty of this population. Unlike intensive care patients, patients aged of 85 and older, having candiduria, do not seem to have a higher risk of candidemia.
The mortality rate associated with candiduria was high in the elderly. This could be more closely linked to age and frailty than to the clinical impact of Candida sp infection. The lack of association between treatment of candiduria and mortality could sustain this hypothesis.
Clinician responses to candiduria are greatly varied and they rarely follow current recommendations (16, 19) . The rate of episodes treated by antifungal agent (21%) was lower than in other studies where it ranged from 33% (16) to 61% (19) . It was difficult to retrospectively evaluate the appropriateness of prescriptions because it was not always easy to differentiate infection of colonization from medical charts.
Among antifungal agents, fluconazole was always used. This is in accordance with the recommendations of the Infectious Diseases Society of America (IDSA) for candiduria (20) . It is often the easiest drug that can be used in oldest old patients who have mild to severe renal impairment and numerous comorbidities with multiple medications. However, the high proportion, in the very old patients, of C. glabrata which have a high level of resistance to fluconazole, could question its use as a probabilistic treatment. In our study, only C. albicans episodes of candiduria were treated.
Immunosuppressive drug was not associated with azole prescription in oldest old, although immunodepression is an indication for treating asymptomatic candiduria (20) . Patients with dementia were undertreated. Medical staff is also probably less aggressive for the care of oldest old patients presenting severe cognitive impairment. They may consider that in this "terminal" stage of dementia, they should provide only comfort care. Thus, the lack of symptom expression or the unusual presentation of signs and symptoms (confusion, falls) (12) could explain the underuse of antifungal treatment. In a non-randomized prospective study, patients with severe dementia receiving antibiotics had no survival benefits compared to those without antibiotic for fever episode (21) . It was different for patients with mild dementia: the estimated mortality rate was 7 times higher in the group that did not receive antibiotics (22) . In the literature, there is no data for antifungal therapies. It is noteworthy that in our study the mortality rate was not associated with the administration of fluconazole. Perhaps, this treatment was over used for treating colonization or, the burden of comorbidities outweighs the impact of treating candiduria. We could not evaluate, in this retrospective study, the effect of fluconazole prescription on candiduria because treatment protocols were too heterogenic and urinary analysis was not systematically controlled at the end of the treatment.
The present study has some limitations mainly related to the retrospective collection of data. We have lost the data mainly on clinical manifestations (that could help to separate colonization from infection) and also on treatment protocol (control of urinary analysis was not performed systematically). This could limit our conclusions on the clinical impact of candiduria and its treatment. We have chosen to collect data from our laboratory data base to have the most exhaustive view of candiduria episode in our hospital because all urinary samples of hospitalized patients are centralized. The selection was done on the biological definition of candiduria because it was the most objective. Indeed, defining urinary tract infection with Candida sp. is difficult since there are no effective diagnostic tests to define whether the presence of yeast in urine is related to colonization or infection. Most of the oldest old patients have multiple comorbidities that complicate recognition of infection. Typical symptoms and signs of infection such as fever are frequently lacking in long-term care facility residents. Some symptoms such as decline in functional status or deteriorating mobility may be the only manifestation of infection in this population (12) . On the other hand, asymptomatic bacteriuria is common in this population without infection. This will increase the major challenge for the clinician to decide whether treatment is indicated or not.
In conclusion, candiduria in the oldest old is common and treating it represents a greater challenge than in the general population because signs and symptoms are often lacking or deceiving. Episodes of candiduria in oldest old are associated with frailty and vulnerability of the patient. The medical decision for antifungal treatment is usually difficult to make for such patients but it does not seem to influence mortality. Predisposing factors of candiduria should be treated or eliminated when possible and eventually an antifungal therapy should be started. Asymptomatic candiduria in the population aged of 85 and over, should not be treated, unless it is associated with neutropenia or a urologic procedure (20) .
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